NEWS & EVENTS

 

PRESS RELEASES

 

NOV 12, 2018

Data from Axcella’s AXA1125 Program Supports New Approach Leveraging Endogenous Metabolic Modulators to Reprogram Cellular Physiology


OCT 22, 2018

Axcella Appoints Stephen Mitchener, PharmD, to Senior Vice President, Chief Business Officer


OCT 22, 2018

Axcella to Present New Data at the Annual 2018 AASLD Liver Meeting


JUNE 27, 2018

Axcella Welcomes William D. Baird, and Cristina M. Rondinone, Ph.D., to Board of Directors

Axcella strengthens legal team with appointments of Paul F. Fehlner, J.D., Ph.D., as Senior Vice President, Chief Intellectual Property Officer and Heidy Abreu King-Jones, J.D., LL.M., as Vice President, Legal and Corporate Secretary


MAY 31, 2018

Axcella Appoints Bill Hinshaw as President and Chief Executive Officer


JAN 3, 2018

Axcella Announces Appointment of David Epstein, Former CEO of Novartis Pharmaceuticals, as Chairman of its Board of Directors

Axcella to present a corporate update at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco


SEPT 14, 2017

Axcella Appoints Manu Chakravarthy, M.D., Ph.D., as Senior Vice President, Chief Medical Officer


JUN 14, 2017

Axcella Appoints Tony Tramontin, Ph.D., as Senior Vice President, Chief Scientific Officer


APR 5, 2017

Axcella to Present at BioCentury’s 24th Annual Future Leaders in the Biotech Industry Conference


MAR 1, 2017

Axcella to Present at the Cowen and Company 37th Annual Health Care Conference


news.jpg

EVENTS

To be announced.